Lung cancer screening is resulting in a higher incidence of early-stage lung cancer diagnoses. This commonly occurs among older patients with chronic lung disease who are at high risk for complications with attaining pathologic confirmation.

The treatment approaches for lung cancer are rapidly evolving and include integration of new systemic therapies (e.g., immunotherapy and targeted therapies) into combined modality approaches for non-metastatic disease and ablative radiation therapy approaches for oligometastatic disease.

This activity focuses on recent and emerging research in radiation oncology for patients with brain and spine tumors. Special emphasis is placed on radiosurgery dose/fractionation selection, IDH inhibition in glioma and glioma contouring/targeting.

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

Patients with Stage IV Lung cancer vary in their response to the numerous systemic therapies and are living longer. The role of aggressive local therapy or metastatic directed therapy (MDT) is critical for radiation oncologists and surgeons.

One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.

The treatment approaches for lung cancer are rapidly evolving, and include integration of new systemic therapies (e.g. immunotherapy and targeted therapies) into combined modality approaches for non-metastatic disease and ablative radiation therapy approaches for oligo-metastatic disease.

While radiation therapy (RT) is a highly effective treatment for many solid tumors, thoracic RT carries a risk of cardiovascular (CV) morbidity and mortality that limits critical gains in cancer control and survival.

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.